Kenneth J Kelley - Net Worth and Insider Trading
Kenneth J Kelley Net Worth
The estimated net worth of Kenneth J Kelley is at least $7 Million dollars as of 2024-04-28. Kenneth J Kelley is the Director of Halozyme Therapeutics Inc and owns about 179,833 shares of Halozyme Therapeutics Inc (HALO) stock worth over $7 Million. Details can be seen in Kenneth J Kelley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth J Kelley has not made any transactions after 2021-04-14 and currently still holds the listed stock(s).
Transaction Summary of Kenneth J Kelley
Kenneth J Kelley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth J Kelley owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of Kenneth J Kelley’s form 4 insider trades.
Insider Ownership Summary of Kenneth J Kelley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-04-14 | director |
Kenneth J Kelley Latest Holdings Summary
Kenneth J Kelley currently owns a total of 1 stock. Kenneth J Kelley owns 179,833 shares of Halozyme Therapeutics Inc (HALO) as of April 14, 2021, with a value of $7 Million.
Latest Holdings of Kenneth J Kelley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2021-04-14 | 179,833 | 38.57 | 6,936,159 |
Holding Weightings of Kenneth J Kelley
Kenneth J Kelley Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth J Kelley has made a total of 8 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 5,000 shares on April 14, 2021, which brought Kenneth J Kelley around $225,000.
Insider Trading History of Kenneth J Kelley
- 1
Kenneth J Kelley Trading Performance
GuruFocus tracks the stock performance after each of Kenneth J Kelley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth J Kelley is 12.75%. GuruFocus also compares Kenneth J Kelley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth J Kelley within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth J Kelley's insider trading performs compared to the benchmark.
Performance of Kenneth J Kelley
Average Return
72.61%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.63 | 12.75 | 16.24 | 72.61 | 31.26 | 36.12 |
| Relative Return to S&P 500(%) | 21.56 | 1.87 | 0.73 | 38.84 | 6.58 | 20.68 |
Kenneth J Kelley Ownership Network
Ownership Network List of Kenneth J Kelley
Ownership Network Relation of Kenneth J Kelley
Kenneth J Kelley Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Kenneth J Kelley is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Kenneth J Kelley made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 235,862 shares made by Michael J. Labarre , a net sale of 251,061 shares made by Helen Torley , and a net sale of 7,525 shares made by Nicole Labrosse .
In summary, during the past 3 months, insiders sold 60,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 564,448 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 564,448 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Kenneth J Kelley Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth J Kelley. You might contact Kenneth J Kelley via mailing address: 1331 Hillview Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
